1. Metabolic Enzyme/Protease Membrane Transporter/Ion Channel
  2. P-glycoprotein Cytochrome P450
  3. (E/Z)-Piperine

(E/Z)-Piperine  (Synonyms: (E/Z)-Bioperine; (E/Z)-1-Piperoylpiperidine)

Cat. No.: HY-W230975 Purity: 98.91%
Handling Instructions Technical Support

(E/Z)-Piperine ((E/Z)-Bioperine) is an alkaloid with a pungent property. (E/Z)-Piperine shows anti-inflammation, immunomodulatory and anti-cancer, antispasmodic and anti-secretory effects. (E/Z)-Piperine demonstrates significant neuroprotective effect in Alzheimer’s disease and Parkinson’s disease.

For research use only. We do not sell to patients.

(E/Z)-Piperine

(E/Z)-Piperine Chemical Structure

CAS No. : 7780-20-3

Size Price Stock Quantity
250 mg In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 Customer Validation

Other Forms of (E/Z)-Piperine:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

(E/Z)-Piperine ((E/Z)-Bioperine) is an alkaloid with a pungent property. (E/Z)-Piperine shows anti-inflammation, immunomodulatory and anti-cancer, antispasmodic and anti-secretory effects. (E/Z)-Piperine demonstrates significant neuroprotective effect in Alzheimer’s disease and Parkinson’s disease[1].

Cellular Effect
Cell Line Type Value Description References
A549 IC50
11.89 μM
Compound: Piperine
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
[PMID: 30108756]
Bel-7402 IC50
>10 μM
Compound: Piperine
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 33026807]
BTI-TN-5B1-4 IC50
1.05 μM
Compound: 1
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
[PMID: 31711793]
Caco-2 IC50
15.5 μM
Compound: Piperine
TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) (Digoxin: 5 uM) in Caco-2 cells
TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) (Digoxin: 5 uM) in Caco-2 cells
[PMID: 12130727]
Caco-2 IC50
74.1 μM
Compound: Piperine
TP_TRANSPORTER: inhibition of Cyclosporin A transepithelial transport (basal to apical) (Cyclosporin A: 1 uM) in Caco-2 cells
TP_TRANSPORTER: inhibition of Cyclosporin A transepithelial transport (basal to apical) (Cyclosporin A: 1 uM) in Caco-2 cells
[PMID: 12130727]
COLO 205 IC50
46 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
10.1007/s00044-010-9500-5
DLD-1 IC50
<200 μM
Compound: 58
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
[PMID: 33445154]
DU-145 IC50
>50 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
10.1007/s00044-010-9500-5
HCT-116 IC50
<200 μM
Compound: 58
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
[PMID: 33445154]
HeLa IC50
0.95 μmol
Compound: 1
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
10.1007/s00044-013-0541-4
HeLa IC50
19.21 μM
Compound: Piperine
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
[PMID: 30108756]
HEp-2 IC50
70 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
10.1007/s00044-010-9500-5
Hepatocyte IC50
12 μM
Compound: 10
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
[PMID: 19775895]
HepG2 IC50
>10 μM
Compound: Piperine
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 33026807]
HepG2 2.2.15 CC50
2.35 mM
Compound: 7
Cytotoxicity against human HepG2(2.2.15) cells
Cytotoxicity against human HepG2(2.2.15) cells
[PMID: 23434420]
HepG2 2.2.15 IC50
0.14 mM
Compound: 7
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion
[PMID: 23434420]
HepG2 2.2.15 IC50
0.15 mM
Compound: 7
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion
[PMID: 23434420]
HUVEC IC50
100 μM
Compound: Piperine
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
10.1039/C2MD20216F
IMR-32 IC50
10.19 μM
Compound: Piperine
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
[PMID: 30108756]
IMR-32 IC50
89 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
10.1007/s00044-010-9500-5
L929 IC50
42 μM
Compound: 10
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
[PMID: 19775895]
MCF7 IC50
0.99 μmol
Compound: 1
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
10.1007/s00044-013-0541-4
MCF7 IC50
12.96 μM
Compound: Piperine
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
[PMID: 30108756]
MCF7 IC50
99 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
10.1007/s00044-010-9500-5
MDA-MB-231 IC50
58.45 μg/mL
Compound: 3
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
10.1007/s00044-012-0397-z
Oocyte EC50
52 μM
Compound: 5
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
[PMID: 20085307]
PC-3 IC50
>50 μM
Compound: 1
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
10.1007/s00044-010-9500-5
SW480 IC50
<200 μM
Compound: 58
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
[PMID: 33445154]
WI-38 IC50
8.8 μM
Compound: 2
Induction of senescence in human WI-38 cells
Induction of senescence in human WI-38 cells
[PMID: 38436272]
In Vitro

Piperine could enhance the bioavailabilities of other drugs including Rosuvastatin (HY-17504A), Peurarin (HY-N0145) and Docetaxel (HY-B0011) via inhibition of CYP3A and P-glycoprotein activity[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

285.34

Formula

C17H19NO3

CAS No.
Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C(N1CCCCC1)/C=C/C=C/C2=CC=C(OCO3)C3=C2

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Store at room temperature 3 years

In solvent -80°C 2 years
-20°C 1 year
Purity & Documentation

Purity: 98.91%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
(E/Z)-Piperine
Cat. No.:
HY-W230975
Quantity:
MCE Japan Authorized Agent: